Lipton v. Pathogenesis Corp.

U.S. Court of Appeals, Ninth Circuit · Decided 2002-03-20

Cited by 141 later decision(s) in our corpus · see the citation network in Lexace

From the opinion

OPINION GOULD, Circuit Judge. Plaintiffs brought this securities fraud class action under §§ 10(b), 20(a) and 20A of the Securities Exchange Act of 1934, 15 U.S.C. §§ 783 (b), 78t(a), 78t-l(a) and Rule 10b-5, 17 C.F.R. § 240 .10b-5, on behalf of all purchasers of PathoGenesis Corporation common stock on the open market between Ja…

Read the full opinion (source) ↗

Lexace provides legal information, not legal advice, and no attorney–client relationship is created. Citation figures are counts of later citing opinions in our corpus and may be incomplete; always read and Shepardize the full opinion before relying on it.